| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2975946 | Journal des Maladies Vasculaires | 2007 | 7 Pages |
Abstract
The choice of clopidogrel in patients with peripheral arterial disease improves the prevention of subsequent events (ischemic and hemorrhagic events) with a cost-effectiveness ratio 2 to 3 times lower than the European thresholds accepted by the World Health Organization and avoids 1Â day of hospitalization for 5.4 treated patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
P. Priollet, G. de Pouvourville,